克劳斯(600579) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2021 was ¥2,396,117,018.93, a decrease of 2.63% compared to the same period last year[3]. - The net profit attributable to shareholders was -¥46,582,405.02, representing a significant decline of 275.58% year-on-year[3]. - The basic earnings per share for the current period was -¥0.06, a decrease of 400.00% compared to the same period last year[5]. - Total revenue for the first three quarters of 2021 was CNY 6,686,597,375.52, a slight decrease of 0.42% compared to CNY 6,714,682,950.03 in the same period of 2020[17]. - Net loss for the third quarter was CNY 222,378,429.77, compared to a net loss of CNY 198,300,246.72 in the previous year, reflecting an increase in losses[18]. - Operating profit for the first three quarters was CNY -316,927,437.45, showing a similar loss compared to CNY -316,273,949.59 in the same period of 2020[17]. - The company’s basic and diluted earnings per share were both CNY -0.30, compared to CNY -0.23 in the same quarter of the previous year, indicating worsening profitability[18]. Assets and Liabilities - The total assets at the end of the reporting period were ¥16,299,146,612.00, reflecting an increase of 1.82% from the end of the previous year[5]. - Total assets amounted to CNY 16,299,146,612.00, up from CNY 16,007,184,807.06 at the end of the previous year[17]. - Total liabilities increased to CNY 11,369,245,970.02 from CNY 10,697,097,605.59, indicating a rise in financial obligations[17]. - The total liabilities increased to ¥11,272,905,332.43 in Q3 2021, up by ¥575,807,726.84 from ¥10,697,097,605.59 in Q3 2020, representing an increase of about 5.4%[24]. - The company reported a decrease in total equity to CNY 4,929,900,641.98 from CNY 5,310,087,201.47, reflecting a decline in shareholder value[17]. - The company’s total equity decreased slightly to ¥5,310,087,201.47 in Q3 2021 from ¥5,301,779,489.78 in Q3 2020, indicating a marginal decline[24]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥697,294,510.80, with a notable increase of 538.81% due to improved sales collections and increased advance payments from new orders[8]. - The net cash flow from operating activities for Q3 2021 was ¥697,294,510.80, a significant improvement compared to a negative cash flow of ¥158,904,889.83 in Q3 2020[21]. - Cash inflow from operating activities was CNY 8,588,287,362.32, an increase of 5.65% from CNY 8,129,818,373.95 in the previous year[20]. - The cash inflow from financing activities was reported at ¥564,200,000.00 in Q3 2021, down from ¥1,631,680,115.56 in Q3 2020, showing a decrease of approximately 65.4%[21]. Inventory and Orders - The company experienced a 36.19% increase in inventory due to rapid order growth and global supply chain constraints[9]. - Inventory as of September 30, 2021, was RMB 2,997,592,024.20, up from RMB 2,201,075,413.62 at the end of 2020[15]. - The company signed new orders totaling approximately RMB 8.846 billion in the first three quarters of 2021, representing a year-on-year increase of 41.33%[14]. - The backlog of orders as of September 30, 2021, was approximately RMB 7.084 billion, with a year-on-year increase of 40.69% for KM Group[14]. - KM Group's new orders amounted to €9.55 million, approximately RMB 739 million, reflecting a year-on-year increase of 49.94%[14]. - Tianhua Institute's new orders reached RMB 1.262 billion, a year-on-year increase of 24.05%[14]. Operational Challenges - The company faced delays in product delivery due to global supply chain issues, impacting sales revenue in the first three quarters of 2021[14]. - The company incurred non-operating losses totaling -¥12,957,009.36 for the current period, influenced by various non-recurring items[8]. - The company’s financial expenses increased, contributing to the overall decline in net profit for the current period[8]. - The company plans to enhance product delivery cycles by reallocating global resources and assisting suppliers with raw material supply issues[14]. Research and Development - Research and development expenses for the first three quarters were CNY 177,131,459.81, up from CNY 166,560,659.38 in the previous year, indicating a focus on innovation[17].